FDA inspection
Merck Sharp & Dohme Corp.: FDA inspection ending Sep 27, 2013
FDA inspection 851665 · Official Action Indicated (OAI) · Ambler, PA
Key facts
| Inspection ID | 851665 |
|---|---|
| Firm | Merck Sharp & Dohme Corp. |
| FEI number | 3010489800 |
| Address | 321 Norristown Rd Ste 215 |
| City | Ambler |
| State | PA |
| ZIP | 19002 |
| Country | United States |
| Fiscal year | 2013 |
| Inspection end date | Sep 27, 2013 |
| Classification | Official Action Indicated (OAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data